• Markets
  • icon
  • Companies
FRE · ASX

Firebrick Pharma Limited (ASX:FRE)

AU$0.079

 -0.006 (-7.059%)
ASX:Live
19/04/2024 03:21:49 PM
HALO Price Momentum HALO Ords GROWTH AUS Big Candle All-Companies
Consensus Score
/10
Recommend
Target Price
Deviation
Unlock Full Consensus Insights

FRE Overview

FRE Health Scores

Short Term

Mean Revision

Neutral

Trend

Neutral

Event

Neutral

Halo Model

MQV

Very Strong

GARP

Very Strong

MQV Small

Neutral

Valuation

Value

Consensus

Momentum

Price

Very Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

FRE Price Chart

Key Stats

Market Cap

n/a

PE

N/A

EV/EBITDA

N/A

Dividends Overview

DIV Yield

N/A

Franking

N/A

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 0.0 - 0.0

Trade Value (12mth)

N/A

1 week

49.06%

1 month

54.9%

YTD

58%

1 year

-59.49%

All time high

N/A

Key Fundamentals

EPS 3 yr Growth

N/A

EBITDA Margin

N/A

Operating Cashflow

N/A

Free Cash Flow Return

N/A

ROIC

N/A

Interest Coverage

N/A

Quick Ratio

N/A

Other Data

Shares on Issue (Fully Dilluted)

N/A

HALO Sector

Next Company Report Date

N/A

Ex Dividend Date (est.)

N/A

Next Dividend Pay Date (est.)

N/A

Reporting Currency

N/A

Short Sell (% of issue)

N/A

FRE Announcements

Latest Announcements

Date Announcements

17 April 24

Nasodine Nasal Spray Launch in the USA

×

Nasodine Nasal Spray Launch in the USA

02 April 24

Nasodine Phase 2 COVID-19 Trial Results Published

×

Nasodine Phase 2 COVID-19 Trial Results Published

28 March 24

Becoming a substantial holder

×

Becoming a substantial holder

04 March 24

Nasodine COVID-19 Patent Allowed in US

×

Nasodine COVID-19 Patent Allowed in US

28 February 24

Appendix 4D & Half-Year Financial Report to 31 December 2023

×

Appendix 4D & Half-Year Financial Report to 31 December 2023

29 January 24

Application for quotation of securities - FRE

×

Application for quotation of securities - FRE

24 January 24

Application for quotation of securities - FRE

×

Application for quotation of securities - FRE

24 January 24

Cleansing Notice

×

Cleansing Notice

23 January 24

December 2023 Quarterly Activity Report & Appendix 4C

×

December 2023 Quarterly Activity Report & Appendix 4C

12 January 24

Release of Securities from Escrow

×

Release of Securities from Escrow

27 December 23

Firebrick Closes AAT Appeal

×

Firebrick Closes AAT Appeal

19 December 23

Application for quotation of securities - FRE

×

Application for quotation of securities - FRE

19 December 23

Cleansing Notice

×

Cleansing Notice

29 November 23

Nasodine COVID-19 Patent Granted in South Africa

×

Nasodine COVID-19 Patent Granted in South Africa

17 November 23

Results of Annual General Meeting

×

Results of Annual General Meeting

15 November 23

Firebrick Investor Update

×

Firebrick Investor Update

31 October 23

Firebrick Receives $1.81m R&D Tax Incentive

×

Firebrick Receives $1.81m R&D Tax Incentive

27 October 23

September 2023 Quarterly Activity Report & Appendix 4C

×

September 2023 Quarterly Activity Report & Appendix 4C

17 October 23

Letter to Shareholders & Notice of AGM & Proxy Form

×

Letter to Shareholders & Notice of AGM & Proxy Form

03 October 23

Update on Nasodine Trial and Forward Plans

×

Update on Nasodine Trial and Forward Plans

18 September 23

Notice of AGM and Closing Date for Director Nominations

×

Notice of AGM and Closing Date for Director Nominations

13 September 23

Phase 3 Common Cold Trial Results

×

Phase 3 Common Cold Trial Results

11 September 23

Trading Halt

×

Trading Halt

29 August 23

Appendix 4E & Annual Report FY23

×

Appendix 4E & Annual Report FY23

29 August 23

Corporate Governance Statement

×

Corporate Governance Statement

FRE Fundamentals

Per Share Records

Historical data

Forecasted data

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Per Share, Growth & Valuations
EPS (Basic) AU$ Lock Lock Lock Lock -0.01 -0.02 -0.04 Lock Lock Lock
EPS (Fully Diluted) AU$ Lock Lock Lock Lock -0.01 -0.02 -0.04 Lock Lock Lock
     Growth % Lock Lock Lock Lock -61.8 -56.2 -77.8 Lock Lock Lock
     PE X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     EV/EBITDA X Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
CFPS AU$ Lock Lock Lock Lock -0.01 -0.02 -0.04 Lock Lock Lock
FCFPS AU$ Lock Lock Lock Lock -0.01 -0.03 -0.03 Lock Lock Lock
     Growth % Lock Lock Lock Lock -59.4 -83.1 -86.6 Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A -9.5 -21.9 Lock Lock Lock
DPS AU$ Lock Lock Lock Lock N/A 0.00 0.00 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Yield % Lock Lock Lock Lock N/A N/A N/A Lock Lock Lock
     Payout Ratio % Lock Lock Lock Lock N/A 0 0 Lock Lock Lock
BPS AU$ Lock Lock Lock Lock 0.01 0.05 0.01 Lock Lock Lock
BPS (Tangible) AU$ Lock Lock Lock Lock 0.01 0.05 0.01 Lock Lock Lock
     Growth % Lock Lock Lock Lock 295.8 435.5 -71.4 Lock Lock Lock
Shares Outstanding
Diluted m Lock Lock Lock Lock 169 169 170 Lock Lock Lock
Basic m Lock Lock Lock Lock 169 169 170 Lock Lock Lock

Financial Records

Historical data

Forecasted data

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Income Statement
Sales AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock N/A N/A -79.9 Lock Lock Lock
Selling & General Expenses AU$m Lock Lock Lock Lock 3 5 7 Lock Lock Lock
Gross Income AU$m Lock Lock Lock Lock 0 N/A 0 Lock Lock Lock
     Growth % Lock Lock Lock Lock -72.8 N/A N/A Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Cost of Goods Sold to Sales % Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
EBITDA AU$m Lock Lock Lock Lock -3 -5 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -42.5 -65.4 -44.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -114,773.5 -825,809.6 Lock Lock Lock
Depreciation & Amortisation AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
EBIT AU$m Lock Lock Lock Lock -3 -5 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -42.5 -65.6 -44.8 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -114,941.8 -826,956.6 Lock Lock Lock
Pretax Income AU$m Lock Lock Lock Lock -3 -5 -7 Lock Lock Lock
Income Taxes AU$m Lock Lock Lock Lock 0 -1 0 Lock Lock Lock
Net Income AU$m Lock Lock Lock Lock -2 -4 -7 Lock Lock Lock
     Growth % Lock Lock Lock Lock -62.8 -55.6 -79.2 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -92,054.1 -819,526.7 Lock Lock Lock
Cash Flow Statement
Net Operating Cash Flow AU$m Lock Lock Lock Lock -2 -4 -6 Lock Lock Lock
Capital Expenditures AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Investing Cash Flow AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Financing Cash Flow AU$m Lock Lock Lock Lock 3 10 1 Lock Lock Lock
Free Cash Flow AU$m Lock Lock Lock Lock -2 -4 -6 Lock Lock Lock
     Growth % Lock Lock Lock Lock -98.2 -116.9 -36.6 Lock Lock Lock
     Margin % Lock Lock Lock Lock N/A -1,026.9 -6,969.8 Lock Lock Lock
Franking Balance AU$m Lock Lock Lock Lock N/A N/A 0 Lock Lock Lock
Balance Sheet
Cash & Short-Term Investments AU$m Lock Lock Lock Lock 1 7 2 Lock Lock Lock
Total Assets AU$m Lock Lock Lock Lock 2 9 3 Lock Lock Lock
Long Term Debt AU$m Lock Lock Lock Lock 0 0 0 Lock Lock Lock
Net Debt AU$m Lock Lock Lock Lock -1 -7 -2 Lock Lock Lock
Total Liabilities AU$m Lock Lock Lock Lock 0 0 1 Lock Lock Lock
Equity AU$m Lock Lock Lock Lock 2 8 2 Lock Lock Lock
Invested Capital Lock Lock Lock Lock 2 8 2 Lock Lock Lock
     Growth % Lock Lock Lock Lock 295.8 435.5 -70.1 Lock Lock Lock
Return Ratios
Return on Assets % Lock Lock Lock Lock -138.5 -43.5 -228.1 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -157.8 -45.9 -274.7 Lock Lock Lock
Return on Total Capital % Lock Lock Lock Lock -295.5 -96.5 -127.6 Lock Lock Lock
Return on Invested Capital % Lock Lock Lock Lock -251.9 -77.3 -126.5 Lock Lock Lock
Cash Flow Return on Invested Capital % Lock Lock Lock Lock -199.9 -85.5 -107.5 Lock Lock Lock

Ratios Records

Historical data

Forecasted data

2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Leverage
Interest Cover X Lock Lock Lock Lock N/A -1,142.2 N/A Lock Lock Lock
Debt to EBITDA X Lock Lock Lock Lock 0.4 1.5 0.3 Lock Lock Lock
Net Debt to Equity % Lock Lock Lock Lock -74.5 -86.3 -95.1 Lock Lock Lock
Liquidity
Current Ratio X Lock Lock Lock Lock 7.8 18.5 5.1 Lock Lock Lock
Quick Ratio X Lock Lock Lock Lock 7.8 18.5 5.1 Lock Lock Lock
Cash & ST Inv/Current Assets % Lock Lock Lock Lock 69.0 85.8 90.9 Lock Lock Lock
CFO/Current Liabilities % Lock Lock Lock Lock -901.4 -933.6 -1,142.0 Lock Lock Lock
Balance Sheet Efficiency
Receivables Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Inventory Turnover X Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Working Capital Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Payables Turnover X Lock Lock Lock Lock N/A 879.5 23,793.3 Lock Lock Lock
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
Du Pont
Asset Turnover X Lock Lock Lock Lock 0.0 0.0 0.0 Lock Lock Lock
x Pretax Margin % Lock Lock Lock Lock N/A -118,223.5 -822,143.6 Lock Lock Lock
= Pretax Return on Assets % Lock Lock Lock Lock N/A -55.9 -228.8 Lock Lock Lock
x Tax Rate Complement (1-Tax Rate) % Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
Return on Assets % Lock Lock Lock Lock -138.5 -43.5 -228.1 Lock Lock Lock
x Equity Multiplier (Assets/Equity) % Lock Lock Lock Lock 1.1 1.1 1.2 Lock Lock Lock
Return on Equity % Lock Lock Lock Lock -157.8 -45.9 -274.7 Lock Lock Lock
x Earnings Retention (1-Payout) % Lock Lock Lock Lock N/A 100.0 100.0 Lock Lock Lock
= Reinvestment Rate (%) % Lock Lock Lock Lock N/A -45.9 -274.7 Lock Lock Lock
Operating Cycle
Days of Inventory on Hand Days Lock Lock Lock Lock N/A N/A 0.0 Lock Lock Lock
+ Days of Sales Outstanding Days Lock Lock Lock Lock N/A 70,130.6 268,034.0 Lock Lock Lock
Operating Cycle Days Lock Lock Lock Lock N/A 70,130.6 268,034.0 Lock Lock Lock
- Days of Payables Outstanding Days Lock Lock Lock Lock 82,954.5 N/A 0.0 Lock Lock Lock
Net Operating Cycle Days Lock Lock Lock Lock -82,954.5 70,130.6 268,034.0 Lock Lock Lock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

N/A

Franking Level

N/A

DPSg

0.00%

Quality Yield

Lock

Falling Divs over next 2

Lock

Values and Recommendations

Key Stats

Consensus Score

Lock

Recommendation

Lock

EPS 1 month Change

Lock

Quality Yield

Lock

Falling Divs over next 2

Lock

Halo Consensus Score

Lock Chart

PEG Ratio

Lock Chart

Consensus EPS Revisions

Lock Chart

Short selling

Key Stats

Percent of Issue

0.00%

Value ($M)

0

Prior Change

N/A

7 Day Change

N/A

1 Month Change

N/A

3 Month Change

N/A

Discover
Short-selling
Opportunities

Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.

FRE Shortsell

Frequently Asked Questions

The current share price of Firebrick Pharma Limited (FRE:ASX) is AU$0.079.
The 52-week high share price for Firebrick Pharma Limited (FRE:ASX) is AU$0.00.
The 52-week low share price for Firebrick Pharma Limited (FRE:ASX)? is AU$0.00.
Firebrick Pharma Limited (FRE:ASX) does not pay a dividend.
Firebrick Pharma Limited (FRE:ASX) does not pay a dividend.
Firebrick Pharma Limited (FRE:ASX) does not offer franking credits.
Firebrick Pharma Limited (FRE:ASX) is classified in the Healthcare.